Wound care clinicians are already aware that hyperbaric oxygen (HBO) therapy is used for more than just decompression illness in deep sea divers. It is also approved for the enhancement of healing in selected problem wounds. Other approved uses include carbon monoxide poisoning, crush injuries, compartment syndrome, acute traumatic ischemia, delayed radiation injury to soft tissue and bony necrosis, compromised skin grafts and burns, and refractory osteomyelitis. 1 The Undersea & Hyperbaric Medical Society defined hyperbaric therapy as therapy in which the patient intermittently breathes 100% oxygen, while the pressure exerted on the body within the treatment chamber is raised to greater than 1 atmosphere absolute (atm abs). 1 For divers, this would be the total pressure of water exerted on the body. Normal atmospheric pressure at sea level is 1 atm abs or ATA. 2 With HBO therapy, oxygen is delivered at 1.5 to 3 ATAs. 2 
HBO THERAPY
Hyperbaric oxygen therapy can be administered in either a single-person or multiperson chamber. 1 Monoplace (singleperson) chambers are pressurized with oxygen, whereas multiplace (multiperson) chambers are pressurized with air, and oxygen is provided via mask, tent, or endotracheal tube. 3 The pressure increase in the chamber must be systematic. The first phase, compression, increases the atmospheric pressure within the chamber. This might cause the recipient to experience pressure on the ears and sinuses that may be relieved by decongestants, yawning, or the Valsalva maneuver. 4 The second phase consists of the prescribed constant pressure followed by decompression in which the atmospheric pressure returns to normal. 2 Hyperbaric oxygen treatments are administered 1 to 2 times daily and last 60 to 90 minutes.
Mechanism of Action
Many chronic wounds fail to heal because of local tissue ischemia or ischemia-reperfusion injury. 5 Hyperbaric oxygen is used as it is reported to be effective in increasing oxygen availability and enhancing healing. Oxygen availability at the tissue level is critical for wound healing. It has been theorized that, during HBO therapy, cellular oxygen concentrations in the plasma and tissue increase. 4, 6 The increased atmospheric pressure propels oxygen through the skin, further enhancing oxy-gen delivery to the tissues. 2 The increase in arterial oxygen pressure (PaO 2 ) results in vasoconstriction and aids in the reduction of edema.
Vasoconstriction causes less blood flow into the capillary bed, thus creating a pressure gradient aiding in the absorption of fluid into the venous system. With the reduction in capillary pressure, there is an enhanced flow of hyperoxygenated plasma to the tissues, enhancing angiogenesis and ultimately collagen formation to aid in wound healing. 2, 7 This effect can last from 2 to 4 hours after the conclusion of the treatment. 8 
Action against Microorganisms
Hyperbaric oxygen therapy has been found to be effective against anaerobic bacteria 6 and, to a lesser extent, against aerobic bacteria. Anaerobic bacteria are able to survive better in the body's deeper tissues where there is a limited oxygen supply. 9 HBO therapy's effectiveness against anaerobic bacteria is through its ability to enhance delivery of oxygen to deeper tissues, thus damaging and/or destroying the anaerobic bacteria. The increased generation of oxygen-free radicals damages bacterial DNA strands, exerting a bacteriostatic effect on the wound bed. 3, 10 Increased tissue oxygenation also enhances leukocytes in their ability to fight infection. 6 
Criteria for HBO Therapy
Transcutaneous oximetry can be used to follow and help predict the response to HBO therapy. 11 One criteria for using HBO therapy is a transcutaneous oxygen measurement of less than 40 mm Hg at the wound edges. This should be followed by testing the patient's tissue response to 100% oxygen via mask. The transcutaneous oxygen level should increase by at least 10 mm Hg to receive HBO therapy. The transcutaneous oxygen measurement should be greater than 200 mm Hg after an HBO trial. 12 Fife et al 13 conducted a retrospective analysis of 1144 patients with diabetes who were treated with HBO therapy. They found that a transcutaneous oxygen tension (TcPO 2 ) of 200 mm Hg, measured in the ''periwound'' area in-chamber, was the most effective determinant of success or failure of the therapy. TcPO 2 measurements at sea-level air of less than 15 mm Hg together with a TcPO 2 of less than 400 mm Hg measured in-chamber were the most predictive of HBO therapy failure (reliability = 75.8%, positive predictive value = 73.3%).
CONTRAINDICATIONS AND ADVERSE EFFECTS
Absolute contraindications to HBO therapy include untreated pneumothorax (danger of becoming a tension pneumothorax), restrictive airway disease (air becomes trapped with decompression and can lead to alveolar rupture with the gas expansion), and concomitant chemotherapy (has associated morbidity). 2, 10 Hyperbaric oxygen therapy is considered safe if the therapy does not exceed 2 hours and the pressure does not exceed 3 atm. 4, 14 Myopia is a reversible adverse effect. 4, 14 Other adverse effects include otic, sinus, or pulmonary barotraumas; neurological oxygen toxicity (seen most often with HBO therapy of 4 ATA); and claustrophobia. 4, 14 Air breaks, where oxygen breathing is interrupted, can decrease the risk of oxygen toxicity. 10 
RISKS
Because oxygen is used with HBO therapy, there is always the risk of fire. Strict adherence to precautions with oxygen therapy is necessary. Safety checks are conducted prior to entering the chamber. Some of these include wearing only 100% cotton clothing and avoiding ''all petroleum-based and alcohol-based products.'' 10 A Cochrane review 15 found that the use of HBO therapy significantly reduced the risk of major (above the ankle) amputation in patients with diabetic foot ulcers and that it might improve the possibility of wound healing at 1 year. There is insufficient research to support the use of HBO therapy in other types of chronic wounds. The Cochrane review recommended the conduct of further randomized studies on the use of HBO therapy for chronic wounds.
REIMBURSEMENTS FOR THERAPY
The Centers for Medicare and Medicaid Services reportedly reimburses HBO as an adjunctive therapy for diabetic wounds of the lower extremities if certain conditions are met. For reimbursement, the wound must be of diabetic etiology, classified as grade III or higher by the Wagner classification system, and unresponsive to standard wound therapy for at least 30 consecutive days. HBO therapy will not continue to be covered if there are no measurable signs of healing within any 30-day period of treatment. Medicare does not reimburse for topical oxygen therapy. 16 
RESEARCH ON HBO
Lyon 17 conducted a descriptive, retrospective review of 89 patients with diabetes and lower extremity wounds who were treated at a wound care and HBO center. Patients received 1 of 4 treatment modalities: (1) standard wound care, (2) growth factor therapy, (3) standard wound care therapy plus HBO therapy, and (4) growth factor therapy plus HBO therapy. Wounds were measured initially and weekly for 8 weeks, and wound volume was recorded. All patient groups had an overall decrease in wound size, with 16% experiencing complete healing. Using a 2 Â 2 factorial analysis of covariance, those who received HBO therapy had significantly greater healing than those patients who received only standard wound care or growth factors alone (P < .001). There was no significant synergistic effect (P = .5131) when growth factor therapy and HBO therapy were used together.
Fourteen patients in 1 institution with delayed radiation injuries following treatment for a gynecological cancer unresponsive to symptomatic treatments were treated with HBO therapy. 18 Patients underwent once-daily HBO treatments with a mean total of 328 treatments (range, 20-50 treatments). A retrospective analysis showed that 10 patients healed or showed improvement of more than 50%, which resulted in a success rate of 71%. The percentage improvement was based on the patients' symptoms (eg, fewer stools for those with radiation enteritis or improvement in diameter of skin ulcers).
A retrospective study was conducted to identify potential factors that could affect the nonhealing of wounds during HBO therapy. 11 Seventy-three patients with 85 nonhealing wounds received HBO therapy. Wound measurements were taken with clustering of the groups into 3 categoriesVrobust, minimal, or nonhealing wounds. Cigarette smoking was associated with a poor response (P < .0001) to wound healing. Those with robust healing had higher blood levels of within reference ranges of serum creatinine and urea nitrogen and were significantly younger in age (64.9 vs 70.9 years; P = .0128) than the nonhealing group. Normalized wound area reduction was not statistically significant between diabetic and nondiabetic patients. The authors would raise the question as to whether the HBO therapy, normal level of serum protein, or a combination had the greater impact on healing.
In a systematic review by Goldman, 19 there was a statistical association between HBO therapy and refractory lower extremity osteomyelitis about 85% of the time. A large, randomized controlled trial is needed to clarify the extent of the effect of HBO therapy on osteomyelitis.
A longitudinal, prospective study 20 with purposive sampling examined the quality of life in 15 patients with chronic and/or nonhealing wounds who were receiving HBO therapy. Questionnaires were used before and after HBO therapy. After HBO therapy, the overall quality of life was higher than before HBO therapy (P = .01).
An older study on HBO therapy for pressure ulcers was conducted in 1971 by Rosenthal and Schurman. 21 Eighteen subjects with 39 pressure ulcers were treated with HBO therapy, and their results were compared with 3 controls. There were 22 pressure ulcers (58%) that healed completely and another 5 (13%) that had greater than 50% reduction in wound size, whereas none of the 6 ulcers in the 3 controls healed or decreased in size by greater than 50%.
A qualitative study explored themes of memory and experiences in a convenience sample of seven nonemergency patients experiencing HBO therapy in a multiperson chamber. 22 Subjects' primary concerns included the chamber noise, temperature (cold), oxygen delivery devices (mask or hood), and the uncertainty of treatment. Patient personalities had an influence on the HBO therapy treatment, as well as previous noxious experiences. The information gleaned aided the staff in their efforts to improve patient comfort. For example, the noise in the chamber was improved, air breaks were provided where the mask or hood could be off for a short period, and more hoods were provided in place of the masks for patient comfort.
SUMMARY
Hyperbaric oxygen therapy continues to be discussed as another adjunctive therapy in the continuum of wound care. There is a dearth of evidence from randomized clinical trials on HBO therapy. For evidence-based practice, more randomized, controlled studies need to be conducted with HBO therapy to determine its efficacy in treating other chronic wounds besides those of patients with diabetes.
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